Regulation of SULT1E1 expression in Ishikawa adenocarcinoma cells by tibolone
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Tibolone and its metabolites enhance tissue factor and PAI-1 expression in human endometrial stromal cells: Evidence of progestogenic effectsSteroids, 2005
- Tibolone: Clinical recommendations and practical guidelinesMaturitas, 2005
- Tibolone Is Metabolized by the 3α/3β-Hydroxysteroid Dehydrogenase Activities of the Four Human Isozymes of the Aldo-Keto Reductase 1C Subfamily: Inversion of Stereospecificity with a Δ5(10)-3-KetosteroidMolecular Pharmacology, 2004
- Progestagenic Effects of Tibolone on Human Endometrial Cancer CellsThe Journal of Clinical Endocrinology & Metabolism, 2003
- Receptor profiling and endocrine interactions of tiboloneSteroids, 2003
- Pros and cons of existing treatment modalities in osteoporosis: a comparison between tibolone, SERMs and estrogen (±progestogen) treatmentsThe Journal of Steroid Biochemistry and Molecular Biology, 2002
- Pharmacokinetics of tibolone in early and late postmenopausal womenBritish Journal of Clinical Pharmacology, 2002
- The in Vivo Human Metabolism of TiboloneDrug Metabolism and Disposition, 2002
- Tibolone: a steroid with a tissue-specific mode of actionThe Journal of Steroid Biochemistry and Molecular Biology, 2001
- Human endometrial 3β-hydroxysteroid dehydrogenase/isomerase can locally reduce intrinsic estrogenic/progestagenic activity ratios of a steroidal drug (Org OD 14)The Journal of Steroid Biochemistry and Molecular Biology, 1993